Skyline Advisors, Inc. Merck & Co., Inc. Transaction History
Skyline Advisors, Inc.
- $258 Billion
- Q4 2024
A detailed history of Skyline Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Skyline Advisors, Inc. holds 2,367 shares of MRK stock, worth $224,178. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,367
Previous 2,709
12.62%
Holding current value
$224,178
Previous $308 Million
23.46%
% of portfolio
0.09%
Previous 0.13%
Shares
5 transactions
Others Institutions Holding MRK
# of Institutions
3,969Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$23.8 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$11.5 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.65 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.79 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $240B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...